For ovarian cancer patients going through menopause, whether or not to take hormone replacement therapy (HRT) can be a big question. Now, these patients may have an answer.

Women who have mutations in the BRCA genes are at higher risk of breast and ovarian cancer. Research has suggested that women with these altered genes may also have problems conceiving children and that they go through menopause earlier than women without the defective genes.

About one out of 70 women will be diagnosed with ovarian cancer in their lifetime. Surgically removing the ovaries is one way to prevent this cancer.

Once ovarian cancer has been diagnosed, it takes some general practitioners more than one month to record the diagnosis, according to a new study.